| Typicality: | 0.430 |
| Saliency: | 0.421 |
| in an amount | 14 | other |
| in prophylactic applications | 7 | temporal |
| at dosages | 3 | other |
| composition → be administered to → subject | 20 |
| composition → be administered to → the subject | 3 |
| negative | neutral | positive |
| 0.075 | 0.835 | 0.090 |
| Raw frequency | 23 |
| Normalized frequency | 0.421 |
| Modifier score | 0.500 |
| Perplexity | 95.319 |